Investors with losses are encouraged to contact the firm before March 24, 2021; click here to submit trade information
LOS ANGELES, March 16, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Voyager Therapeutics, Inc. (NASDAQ: VYGR) investors that acquired shares between June 1, 2017 and November 9, 2020. Investors have until March 24, 2021 to seek an active role in this litigation.
It is alleged in the complaint that Voyager made misleading and false statements to the market. Voyager’s IND submission to the FDA for VY-HTT01 failed to include essential information in regard to chemistry, manufacturing and controls matters including product characterization and drug-device compatibility. Based on this failure, Voyager’s IND submission for VY-HTT01 was deficient. Voyager overstated the likelihood of the IND submission achieving FDA approval. Voyager’s public statements were materially misleading and false throughout the class period, based on these facts. Investors suffered damages when the market learned the truth about Voyager.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2021.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.